日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Protocol for the development and validation of a risk score to predict risk of adverse events associated with systemic anti-cancer treatment in late-stage lung cancer: Lung Cancer Improved Decisions (LUCID)

用于开发和验证风险评分以预测晚期肺癌全身抗癌治疗相关不良事件风险的方案:肺癌改善决策(LUCID)

Almossawi, Ofran; Steventon, Luke; Keogh, Ruth; Diaz-Ordaz, Karla; Wang, Zhe; Challenger, Andrew; Dodwell, David; Forster, Martin; Man, Kenneth K C; Wei, Li; Masento, Sebastian; Januszewski, Adam; Chambers, Pinkie

Survival after intensive therapy or clofarabine in fit older adults with acute myeloid leukemia: E2906 phase 3 trial

接受强化治疗或克拉屈滨治疗的急性髓系白血病老年患者的生存情况:E2906 III期试验

Foran, James M; Sun, Zhuoxin; Luger, Selina M; Claxton, David F; Lazarus, Hillard M; Arber, Daniel A; Rowe, Jacob M; Paietta, Elisabeth; Racevskis, Janis; Garrett-Bakelman, Fran; Zhang, Yanming; Altman, Jessica K; Al-Kali, Aref; Zheng, Hong; Pratz, Keith W; Broun, E Randolph; Powell, Bayard L; O'Dwyer, Kristen Marie; Godwin, John E; Ofran, Yishai; Litzow, Mark R; Tallman, Martin S

Hematopoietic cell transplantation soon after first relapse in acute myeloid leukemia - the CONS

急性髓系白血病首次复发后不久进行造血干细胞移植——CONS

Ofran, Yishai; Rowe, Jacob M

Acute myeloid leukemia drug-tolerant persister cells survive chemotherapy by transiently increasing plasma membrane rigidity, that also increases their sensitivity to immune cell killing

急性髓系白血病耐药性持续细胞通过短暂增加细胞膜刚性来抵抗化疗,这种增加也会提高它们对免疫细胞杀伤的敏感性。

Morgenstern, Yael; Lee, JongBok; Na, Yoosu; Lieng, Brandon Y; Ly, Nicholas S; Gwynne, William D; Hurren, Rose; Ma, Li; Ling, Dakai; Gronda, Marcela; Arruda, Andrea; Frisch, Avraham; Zuckerman, Tsila; Ofran, Yishai; Minden, Mark D; Zhang, Li; O'Brien, Catherine; Quaile, Andrew T; Montenegro-Burke, J Rafael; Schimmer, Aaron D

Trial eligibility, treatment patterns, and outcome for venetoclax-based therapy in AML: a prospective cohort study

急性髓系白血病(AML)患者接受维奈托克治疗的入组标准、治疗模式和疗效:一项前瞻性队列研究

Wolach, Ofir; Levi, Itai; Nachmias, Boaz; Tavor, Sigal; Amitai, Irina; Ofran, Yishai; Ganzel, Chezi; Zuckerman, Tsila; Okasha, Doaa; Hellmann, Ilana; Tadmor, Tamar; Dally, Najib; Canaani, Jonathan; Stemer, Galia; Grunspan, Moshe; Berger, Adi Jacob; Frankel, Neta; Berelovich, Jenia; Bleterman, Alexandra; Barak, Moran; Cohen, Raanan; Moshe, Yakir

Pivotal results of SELECT-MDS-1 phase 3 study of tamibarotene with azacitidine in newly diagnosed higher-risk MDS

SELECT-MDS-1 III期研究的关键结果:他米巴罗汀联合阿扎胞苷治疗新诊断的高危MDS

DeZern, Amy E; Thepot, Sylvain; de Botton, Stephane; Patriarca, Andrea; Deeren, Dries; Torregrossa-Diaz, Jose-Miguel; Marconi, Giovanni; Bernal, Teresa; Bergua Burgues, Juan; Xicoy, Blanca; Jonášová, Anna; Zeidan, Amer M; Dimicoli-Salazar, Sophie; Simand, Célestine; Valcarcel, David; Diez Campelo, Maria; Chai-Ho, Wanxing; Saini, Lalit; Garnier, Alice; Geissler, Klaus; Ofran, Yishai; Nagy, Zsolt; Krishnamurthy, Pramila; Lübbert, Michael; Basak, Grzegorz; Carraway, Hetty E; Sallman, David A; Borate, Uma; Santini, Valeria; Campbell, Victoria; Fenaux, Pierre; Braun, Thorsten; Lanza, Francesco; Zaucha, Jan Maciej; Roth, David A; Paul, Sofia; Roy, Pourab; Kelly, Michael J; Volkert, Angela; Chisholm, Jaime; Malak, Tanya Abdul; Klimek, Virginia M; Cluzeau, Thomas

CPX-351 +/- gemtuzumab ozogamicin as induction therapy for adult patients with newly diagnosed, favourable-intermediate risk, FLT3-ITD negative, AML: A pilot study

CPX-351 +/- 吉妥珠单抗奥佐米星作为新诊断的、预后良好至中等风险、FLT3-ITD 阴性急性髓系白血病 (AML) 成人患者的诱导治疗:一项初步研究

Ganzel, Chezi; Frisch, Avraham; Wolach, Ofir; Moshe, Yakir; Krayem, Baher; Dor, Neta; Broide, Etti; Benayoun, Emmanuel; Rowe, Jacob M; Ofran, Yishai

Post-Relapse Outcomes of Older Patients With NPM1-Mutated AML Are Favorable With Allo Transplant in Second Remission

对于携带NPM1突变的AML老年患者,在第二次缓解期进行异基因移植可改善复发后的预后。

Frisch, Avraham; Ganzel, Chezi; Ofran, Yishai; Krayem, Baher; Haran, Arnon; Vainstein, Vladimir; Aumann, Shlomzion; Even-Zohar, Noa Gross; Nachmias, Boaz

Epiglottitis in Patients Treated for Acute Leukemia: Case Series and Systematic Review of the Literature

急性白血病患者会厌炎:病例系列及文献系统综述

Sherban, Adi; Frisch, Avraham; Rozenthal, Alon; Buchrits, Shira; Atamna, Baha; Ben-Ner, Daniel; Eden, Sivan; Atamna, Ala; Ofran, Yishai; Raanani, Pia; Wolach, Ofir

Interactions between immune cell types facilitate the evolution of immune traits

免疫细胞类型之间的相互作用促进免疫特征的进化

Tania Dubovik #, Martin Lukačišin #, Elina Starosvetsky, Benjamin LeRoy, Rachelly Normand, Yasmin Admon, Ayelet Alpert, Yishai Ofran, Max G'Sell, Shai S Shen-Orr